These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4311390)

  • 1. [Biological properties of the A22 foot-and-mouth disease virus].
    Zhidkova LA
    Veterinariia; 1968 Nov; 45(11):23-7. PubMed ID: 4311390
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of temperature during passage on the properties of attenuated foot and mouth disease virus].
    Urvantsev NM; Siusiukin AA; Sergeev VA; Prokhorov VV
    Veterinariia; 1971 Jan; 1():37-9. PubMed ID: 4325013
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the population composition of foot-and-mouth disease virus during the course of a modification in the central nervous system of mice].
    Wagner S
    Arch Exp Veterinarmed; 1966 Sep; 20(4):825-38. PubMed ID: 4298118
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological properties of virus strains, reproduced from infectious ribonucleic acid neurotropic foot-and-mouth disease virus mutants].
    Veckenstedt A; Hantschel H
    Arch Exp Veterinarmed; 1966 Jun; 20(3):581-7. PubMed ID: 4296901
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on pathogenicity and immunogenicity of a cell-culture-modified foot-and-mouth disease virus.
    Seibold HR; Dougherty E; Martinsen JS
    J Am Vet Med Assoc; 1965 Dec; 147(12):1608-17. PubMed ID: 4287070
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the development of myotropic foot-and-mouth disease virus strains in guinea pigs].
    Bengelsdorff HJ; Schneider B
    Zentralbl Bakteriol Orig; 1964 Nov; 194(3):292-305. PubMed ID: 4284150
    [No Abstract]   [Full Text] [Related]  

  • 7. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a methodology for the production of foot- and- mouth disease virus from BHK21 C13 monolayer cells grown in a 100 l (20 m2) glass sphere propagator.
    Whiteside JP; Whiting BR; Spier RE
    Dev Biol Stand; 1979; 42():113-9. PubMed ID: 223915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antigenic properties of type C foot-and-mouth disease virus].
    Fomina MS; Driagalin NN; Shazhko ZhA; Onofriev VP
    Veterinariia; 1970 Sep; 9():40-2. PubMed ID: 4323896
    [No Abstract]   [Full Text] [Related]  

  • 10. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the neurotropic behavior of foot-and-mouth disease standard A virus after intracerebral inoculation. 3. Development of a virus strain with neurotropic properties for the guinea pig].
    Veckenstedt A; Urbaneck D
    Arch Exp Veterinarmed; 1966 Sep; 20(4):731-50. PubMed ID: 4298116
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of cross reacting isolates of foot & mouth disease virus.
    Venkataramanan R; Mukhopadhyay AK; Rao BU
    Indian J Exp Biol; 1983 Mar; 21(3):137-42. PubMed ID: 6197366
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.
    Lobo CA; Cowan KM; Trautman R; Hanson RP
    Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of mutants of foot-and-mouth disease virus obtained by cultivation at low temperature. Selection of strains non-pathogenic in swine].
    Asso J; Aynaud JM; Plart MF
    Ann Inst Pasteur (Paris); 1966 Feb; 110(2):233-43. PubMed ID: 4285751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the foot-and-mouth disease virus cultured on the BHK-21 cell line].
    Mitev G; Tekerlekov P
    Vet Med Nauki; 1973; 10(4):3-8. PubMed ID: 4370848
    [No Abstract]   [Full Text] [Related]  

  • 16. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
    Das BR; Pattnaik B; Venkataramanan R; Rai DV
    Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological behaviour of cross reacting foot & mouth disease virus isolates.
    Venkataramanan R; Mukhopadhyay AK; Rao BU
    Indian J Exp Biol; 1983 Mar; 21(3):134-6. PubMed ID: 6197365
    [No Abstract]   [Full Text] [Related]  

  • 18. Some experiences with chemical inactivants of foot-and-mouth disease virus.
    Fellowes ON
    J Immunol; 1967 Sep; 99(3):508-13. PubMed ID: 4293089
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple quantitative microtest for determination of the complement fixing activity of foot-and-mouth disease virus.
    Petr G; Láznicka F
    Acta Virol; 1972 Mar; 16(2):133-40. PubMed ID: 4401070
    [No Abstract]   [Full Text] [Related]  

  • 20. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.